These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18982298)

  • 1. Mapping the regions of RNase P catalytic RNA that are potentially in close contact with its protein cofactor.
    Trang P; Liu F
    Methods Mol Biol; 2008; 488():267-77. PubMed ID: 18982298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of RNase P Ribozyme Regions in Proximity with a Human RNase P Subunit Protein Using Fe(II)-EDTA Cleavage and Nuclease Footprint Analyses.
    Trang P; Smith A; Liu F
    Methods Mol Biol; 2023; 2666():55-67. PubMed ID: 37166656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing RNase P ribozymes for gene-targeting and antiviral therapy.
    Trang P; Kim K; Liu F
    Cell Microbiol; 2004 Jun; 6(6):499-508. PubMed ID: 15104592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General design and construction of RNase P ribozymes for gene-targeting applications.
    Zou H; Chan K; Trang P; Liu F
    Methods Mol Biol; 2004; 252():385-98. PubMed ID: 15017065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping RNA-protein interactions in ribonuclease P from Escherichia coli using disulfide-linked EDTA-Fe.
    Biswas R; Ledman DW; Fox RO; Altman S; Gopalan V
    J Mol Biol; 2000 Feb; 296(1):19-31. PubMed ID: 10656815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the protein cofactor on the interactions between an RNase P ribozyme and its target mRNA substrate.
    Hsu AW; Kilani AF; Liou K; Lee J; Liu F
    Nucleic Acids Res; 2000 Aug; 28(16):3105-16. PubMed ID: 10931926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping in three dimensions of regions in a catalytic RNA protected from attack by an Fe(II)-EDTA reagent.
    Westhof E; Wesolowski D; Altman S
    J Mol Biol; 1996 May; 258(4):600-13. PubMed ID: 8636995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein cofactor-dependent acquisition of novel catalytic activity by the RNase P ribonucleoprotein of E. coli.
    Cole KB; Dorit RL
    J Mol Biol; 2001 Apr; 307(5):1181-212. PubMed ID: 11292334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of the in vitro antiviral activity of an engineered M1GS ribozyme that targets to the core gene of hepatitis C virus].
    Zhang W; Li X; Luo G; Huang Z; Liu Y
    Wei Sheng Wu Xue Bao; 2013 Aug; 53(8):875-81. PubMed ID: 24341280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of ribonuclease P--a universal ribozyme.
    Torres-Larios A; Swinger KK; Pan T; Mondragón A
    Curr Opin Struct Biol; 2006 Jun; 16(3):327-35. PubMed ID: 16650980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of RNase P ribozyme for gene-targeting applications.
    Raj SM; Liu F
    Gene; 2003 Aug; 313():59-69. PubMed ID: 12957377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro selection of RNase P ribozymes that efficiently cleave a target mRNA.
    Kim K; Liu F
    Methods Mol Biol; 2004; 252():399-412. PubMed ID: 15017066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate.
    Trang P; Hsu AW; Liu F
    Nucleic Acids Res; 1999 Dec; 27(23):4590-7. PubMed ID: 10556315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mRNAs by engineered sequence-specific RNase P ribozymes.
    Bai Y; Sunkara N; Liu F
    Methods Mol Biol; 2012; 848():357-68. PubMed ID: 22315080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping RNA-protein interactions in ribonuclease P from Escherichia coli using electron paramagnetic resonance spectroscopy.
    Gopalan V; Kühne H; Biswas R; Li H; Brudvig GW; Altman S
    Biochemistry; 1999 Feb; 38(6):1705-14. PubMed ID: 10026248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ribozyme derived from the catalytic subunit of RNase P from Escherichia coli is highly effective in inhibiting replication of herpes simplex virus 1.
    Trang P; Kilani A; Kim J; Liu F
    J Mol Biol; 2000 Aug; 301(4):817-26. PubMed ID: 10966788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead(II) cleavage analysis of RNase P RNA in vivo.
    Lindell M; Brännvall M; Wagner EG; Kirsebom LA
    RNA; 2005 Sep; 11(9):1348-54. PubMed ID: 16043496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic M1GS RNA as an antiviral agent in animals.
    Bai Y; Rider PJ; Liu F
    Methods Mol Biol; 2010; 629():339-53. PubMed ID: 20387160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered RNase P ribozymes increase their cleavage activities and efficacies in inhibiting viral gene expression in cells by enhancing the rate of cleavage and binding of the target mRNA.
    Zou H; Lee J; Kilani AF; Kim K; Trang P; Kim J; Liu F
    J Biol Chem; 2004 Jul; 279(31):32063-70. PubMed ID: 15169770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.